health biotech news today obesity drugs glp-1 market sales potential tightens as Novo and Lilly enter new era Skyrocketing Cost of Obesity Drugs

Broad utility as a mechanistic probe in skin and wound-healing biology

In just one week after receiving their final dose of Melanotan 2, measurements in the subjects confirmed a quantifiable increase in their skin pigmentation

Culture of preimplantation embryos: facts and artifacts

(29733464) Lacosamide has several advantages over valproic acid and fosphenytoin, including excellent safety, minimal drug-drug interactions, and reliable pharmacokinetics

Conclusions The study findings indicate that the use of GLP-1 receptor agonists is not associated with an increased risk of self-harm, suicidal ideation, and suicide as compared to DPP-4 and SGLT-2 inhibitors among T2D patients